Enliven Therapeutics Inc (ELVN)
$44.25 -1.84% Close Oct 30, 2026 Live
Enliven Therapeutics stock today
Enliven Therapeutics closed at $44.25 on October 30, 2026, down 1.84% on the day. Over the past year it returned +84.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.69 billion.
$20.00$40.00$60.00
NovJan 2026MarMayJulSep
| Period | ELVN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.5% | -0.9% |
| 3 months | -18.0% | +2.1% |
| Year to date | +187.3% | +11.7% |
| 1 year | +84.6% | +12.4% |
| 3 years | +269.1% | +88.5% |
| 5 years | +207.3% | +76.0% |
Key statistics
- Market value
- $2.69B
- 52-week range
- $15.14 to $61.15
- Next report
- Nov 11, 2026 (estimated)
About Enliven Therapeutics
Biopharmaceutical company developing small-molecule drug candidates for cancer treatments.
Sector: Health Care
More on Enliven Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $3,073 today
No forecast, no recommendation. This page describes Enliven Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.